Flyover Conservatives

Who Is Vivek Ramaswamy?

(Intro)

Vivek Ramaswamy | Who Is Vivek Ramaswamy? 16 Facts You Need to Know! Why Did Ramaswamy’s Roivant & Pfizer Team Up to Unveil Priovant Therapeutics? Why Did Ramaswamy’s Roivant List Subsidiary Companies In China As Recently As February 2022?  
  Vivek Ramaswamy | Who Is Vivek Ramaswamy? 16 Facts You Need to Know! Why Did Ramaswamy's Roivant & Pfizer Team Up to Unveil Priovant Therapeutics? (See the Video Description for All Supporting FACTS) --
Vivek Ramaswamy is listed on the Paul (brother of George Soros) & Daisy Soros Fellowships for New Americans website. Vivek Ramaswamy’s voting record shows that he is not a registered Republican as of August of 2023 and he donated to Anti-Trump democrat candidates in 2016. At the age of 29, Ramaswamy started Roivant Sciences in 2014. In 2021, Roivant grew its computational drug discovery engine with the acquisition of Silicon Therapeutics, Silicon Therapeautics provides physics-based approaches at to be integrated with machine learning-based approaches at VantAI. In 2022 Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases. In 2020 Ramaswamy posted on his Twitter account: “Wearing a Mask = Personal Responsibility. It’s Puzzling When Conservatives Oppose It.”  

Who Is Vivek Ramaswamy (Born August 9th 1985)?

Age 37, Vivek Ramaswamy, in 2014, Ramaswamy founded the biopharmaceutical company Roivant Sciences after working as an investment partner at a hedge fund. After stepping down as Roivant’s chief executive in 2021, Ramaswamy co-founded and has served as executive chairman of Strive Asset Management, an investment firm countering traditional emphasis on corporate social responsibility. In February 2023, Ramaswamy declared his candidacy for the Republican Party’s nomination for president in the 2024 election.  
Vivek Ramaswamy | How Did Vivek Ramaswamy Become a Billionaire? + 19 Facts You Need to Know! Why Did Ramaswamy’s Roivant & Pfizer Team Up to Unveil Priovant Therapeutics? (See the Video Description for All Supporting FACTS)  
  Vivek Ramaswamy | How Did Vivek Ramaswamy Become a Billionaire? + 19 Facts You Need to Know! Why Did Ramaswamy's Roivant & Pfizer Team Up to Unveil Priovant Therapeutics? (See the Video Description for All Supporting FACTS) --
FACT #21 – 2023 (Age 38) Roivant Loses Copious Amounts of Money Year After Year | Virtually All of Ramaswamy’s Companies Consistently Lose Money And None Have Ever Turned a Profit Consistently  
2023 – Roivant Is Predicted to Lose Another $1.03 Billion According to Bloomberg / Fortune –  
2022 – Roivant Lost $1.12 Billion In 2022  
2021 – Roivant Lost $698 Million In 2021  
2020 – Roivant Lost $433 Million In 2020  
FACT #20 – 2023 – (Age 38) Roivant Set Up a New Subsidiary, Telavant, to Advance the Asset. Pfizer Owns 25% of Telavant and retains the rights to RVT-3101 outside of the U.S. and Japan. According to the WSJ, Roche is nearing a deal to buy Roivant’s rights to the molecule  
READ –  
.  
FACT #19 – 2023 – (Age 38) Vivek Ramaswamy’s Pharmacy Firm to Sell Experimental Drug In $7B Deal –  
READ –  
FACT #18 – 2022 (June 28) – (Age 37) Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus  
READ –  
FACT #17 – 2022 – (Age 37) As Recently As February 2022, Ramaswamy’s Roivant Listed Subsidiary Companies In China, According to SEC Filings:-  
READ –  
FACT #16 – 2022 – (Age 37) Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases  
READ –  
FACT #15 – 2021 – (Age 36) Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics | Silicon Therapeautics provides physics-based approaches at to be integrated with machine learning-based approaches at VantAI  
READ –  
FACT #14 – (May 3rd) (Age 36) – (Vivek Put an Estimated $950 Million In the Bank While Achieving a Billion Dollar Net Worth from Having Taken Roivant Public)  
READ –  
FACT #13 – 2021 – (February 24) (Age 36) – “To State the Obvious: We Should Aim to Safely Vaccinate Everyone Who Is Eligible.” – Vivek Ramaswamy  
READ –  
FACT #12 – 2020 – (November 9, 2020) (Age 35) – Ramaswamy’s Datavant Sought to Create a Universal Database for Governments That Displays “Every Patient Who Has Been Tested for COVID-19.” – Ramaswamy Wanted to “Fight COVID-19” by Manufacturing a “Single Repository of All the Real-World Medical Data” Thanks to the Production of a “National Data Infrastructure” of Private and Public Patient Records, All Without the Consent of the Actual Patients. Ramaswamy’s Datavant Sought to Profit Off of the Hysteria And Violate Basic Ethical Standards In the Process. Datavant Succeeded In Establishing a Partnership with the National Institutes of Health (NIH).  

Read Vivek’s Thesis | The Chimera Question

  Gravitas: Scientists inject human cells into Monkey's embryo --
https://www.youtube.com/watch?v=MzTwyzAeIxM
What Is a Chimera? The Term “Chimera” Has Come to Describe Any Mythical or Fictional Creature with Parts Taken from Various Animals, to Describe Anything Composed of Disparate Parts or Perceived as Wildly Imaginative, Implausible, or Dazzling.  
READ –  
Why the Moratorium on Human-Animal Chimera Research Should Not Be Lifted  
READ –  

All Resources